Dr. Mehee Choi is a board-certified radiation oncologist who has been in practice for more than seven years, since completing residency training at Northwestern Memorial Hospital in 2013. Her training and experience in academic and community practices has allowed her to develop expertise in a wide variety of disease sites and techniques. She’s well-versed in 3D conformal radiation therapy, IMRT, volumetric arc therapy, 4D-CT, deep inspiration breath hold radiation therapy treatments, linac-based stereotactic radiosurgery, and stereotactic radiation therapy. She has some experience with intraoperative radiotherapy (INTRABEAM), hyperthermia, proton beam radiotherapy, Gamma Knife radiosurgery, and brachytherapy. Dr. Choi is also Director of Medical Science for GT Medical Technologies, the maker of GammaTile Therapy.
During these uncertain times, remember to proactively reach out to patients and encourage them to resume routine cancer screenings to prevent delayed diagnoses that might lead to worsened health outcomes
Intracranial brachytherapy was recently improved through the development of a surgically targeted radiation therapy comprised of Cesium-131 radiation seeds embedded in a bioresorbable collagen tile.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.